Perspectives on clonogenic tumor cells, stem cells, and oncogenes.

The last decade has seen major advances in both cellular and molecular aspects of cancer biology. Tissue culture methods that allow the recognition of clonogenic cells within human tu mors have been described (37, 64); on the basis of theoretical arguments and the application of these techniques, it has been proposed that neoplasms may be regarded as stem cell systems in which a minority of cells have the proliferative capacity to maintain the tumor whereas the majority of cells demonstrate differentiation features and have limited proliferative potential. This view has been summarized as a "stem cell" model of tumor growth (59) and is consistent with data concerning normal cell renewal (83) and with analysis of kinetics of survival of neoplastia cells following treatment (101). In parallel with these developments, investigations regarding the molecular biology of neoplasia have shown that aspects of the malignant character of human tumors are governed by the "activation" and/or the inappropriate expression of certain cellular genes that resemble retroviral transforming genes (oncogenes) (reviewed in Ref. 50). Some 20 such genes ("c-onc" genes) have been described; their relationship to carcinogenesis has been attributed to point mutations in a c-onc sequence creating an abnormal gene product or to loss of regulation of transcription of c-onc genes arising through processes such as gene amplifi cation or translocation to a transcriptionally active area of a chromosome. Recently, evidence of relationships between c-onc genes, endogenous peptide growth factors, and the control systems that regulate entry into cell cycle and subsequent pro liferative behavior has been presented. These two sources of information (tumor stem cell organization and oncogene activation) have not previously been integrated. We will first present our perspectives of the anticipated impact of research on clonogenic cells on tumor biology and clinical oncology. Subsequently, we will review certain key observations related to oncogenes and attempt to establish an integration between the concept of cell heterogeneity (imposed by viewing a tumor as a stem cell system) and results showing that c-onc gene transcription is related to cell differentiation and can be modulated by certain growth factors.

[1]  H. Ruley Adenovirus early region 1A enables viral and cellular transforming genes to transform primary cells in culture , 1983, Nature.

[2]  M. Barbacid,et al.  Induction of mammary carcinomas in rats by nitroso-methylurea involves malignant activation of H-ras-1 locus by single point mutations , 1983, Nature.

[3]  P. Leder,et al.  Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor , 1983, Cell.

[4]  P. Vogt Spontaneous segregation of nontransforming viruses from cloned sarcoma viruses. , 1971, Virology.

[5]  T. Graf,et al.  The cellular oncogenes c-myc, c-myb and c-erb are transcribed in defined types of avian hematopoietic cells. , 1983, Experimental cell research.

[6]  J. Till,et al.  COLONY ASSAY FOR PROLIFERATIVE BLAST CELLS CIRCULATING IN MYELOBLASTIC LEUKÆMIA , 1977, The Lancet.

[7]  G. Steel,et al.  Growth kinetics of tumours : cell population kinetics in relation to the growth and treatment of cancer , 1977 .

[8]  E. McCulloch,et al.  Self-renewal capacity of leukemic blast progenitor cells. , 1981, Cancer research.

[9]  A. Hamburger,et al.  Primary bioassay of human myeloma stem cells. , 1977, The Journal of clinical investigation.

[10]  W. Mackillop,et al.  Density/volume analysis in the study of cellular heterogeneity in human ovarian carcinoma. , 1982, British Journal of Cancer.

[11]  G. Carpenter,et al.  Visualization of epidermal growth factor receptors in human epidermis. , 1984, The Journal of investigative dermatology.

[12]  D. Basketter,et al.  Distribution and number of epidermal growth factor receptors in skin is related to epithelial cell growth. , 1983, Developmental biology.

[13]  R. Weinberg,et al.  Passage of phenotypes of chemically transformed cells via transfection of DNA and chromatin. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[14]  J. Bishop,et al.  The protein products of the myc and myb oncogenes and adenovirus E1a are structurally related , 1983, Nature.

[15]  P. Reitsma,et al.  Regulation of myc gene expression in HL-60 leukaemia cells by a vitamin D metabolite , 1983, Nature.

[16]  V. Courtenay,et al.  Growth of human tumour cell colonies from biopsies using two soft-agar techniques. , 1978, British Journal of Cancer.

[17]  J. Trent,et al.  Development of an agar-methyl cellulose clonogenic assay for cells in transitional cell carcinoma of the human bladder. , 1979, Cancer research.

[18]  M. Barbacid,et al.  Oncogenes in solid human tumours , 1982, Nature.

[19]  T. Papayannopoulou,et al.  Chronic myelocytic leukemia: clonal origin in a stem cell common to the granulocyte, erythrocyte, platelet and monocyte/macrophage. , 1977, The American journal of medicine.

[20]  V. Courtenay,et al.  An in vitro colony assay for human tumours grown in immune-suppressed mice and treated in vivo with cytotoxic agents. , 1978, British Journal of Cancer.

[21]  J. Minna,et al.  Amplification and expression of the c-myc oncogene in human lung cancer cell lines , 1983, Nature.

[22]  A. Gazdar,et al.  Demonstration of the stem cell nature of clonogenic tumor cells from lung cancer patients. , 1982, Stem cells.

[23]  M. Gonda,et al.  Analysis of two divergent rat genomic clones homologous to the transforming gene of Harvey murine sarcoma virus. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[24]  Goldie Jh,et al.  Quantitative model for multiple levels of drug resistance in clinical tumors. , 1983 .

[25]  H. Varmus,et al.  Uninfected vertebrate cells contain a protein that is closely related to the product of the avian sarcoma virus transforming gene (src). , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[26]  K. Oshimi,et al.  Proliferative state and radiosensitivity of human myeloma stem cells. , 1982, British Journal of Cancer.

[27]  S. Salmon,et al.  Human myeloma in vitro colony growth: interrelationships between drug sensitivity, cell kinetics, and patient survival duration. , 1983, Blood.

[28]  D. Alberts,et al.  Quantitation of differential sensitivity of human-tumor stem cells to anticancer drugs. , 1978, The New England journal of medicine.

[29]  L. Fink,et al.  Cancer : a problem of developmental biology , 1978 .

[30]  T. Sun,et al.  Epidermal stem cells. , 1983, The Journal of investigative dermatology.

[31]  E. McCulloch,et al.  The contribution of blast cell properties to outcome variation in acute myeloblastic leukemia (AML). , 1982, Blood.

[32]  Eugenio Santos,et al.  A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogene , 1982, Nature.

[33]  S. Reed,et al.  Primary structure homology between the product of yeast cell division control gene CDC28 and vertebrate oncogenes , 1984, Nature.

[34]  E. McCulloch,et al.  A colony assay for blast cell progenitors in non-B non-T (common) acute lymphoblastic leukemia. , 1981, Blood.

[35]  A. Houweling,et al.  The relationship between region E1a and E1b of human adenoviruses in cell transformation. , 1982, Gene.

[36]  D. Gospodarowicz,et al.  Epidermal growth factor and expression of specific genes: effects on cultured rat pituitary cells are dissociable from the mitogenic response. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[37]  R. Weinberg,et al.  Characterization of a human colon/lung carcinoma oncogene , 1983, Nature.

[38]  R. Weinberg,et al.  Transforming genes of carcinomas and neuroblastomas introduced into mouse fibroblasts , 1981, Nature.

[39]  R. Huebner,et al.  Oncogenes of RNA tumor viruses as determinants of cancer. , 1969, Proceedings of the National Academy of Sciences of the United States of America.

[40]  N. Glaichenhaus,et al.  The roles of individual polyoma virus early proteins in oncogenic transformation , 1982, Nature.

[41]  S. Salmon,et al.  In vitro clonal assay for human metastatic melanoma cells. , 1981, Stem cells.

[42]  P. Rous Landmark article (JAMA 1911;56:198). Transmission of a malignant new growth by means of a cell-free filtrate. By Peyton Rous. , 1983, JAMA.

[43]  J. Brugge,et al.  Characterization of a normal avian cell protein related to the avian sarcoma virus transforming gene product , 1978, Cell.

[44]  R. Makuch,et al.  Association between human tumor colony-forming assay results and response of an individual patient's tumor to chemotherapy. , 1981, The American journal of medicine.

[45]  R. Buick In vitro clonogenicity of primary human tumor cells: quantitation and relationship to tumor stem cells. , 1980, Progress in clinical and biological research.

[46]  A. Otto,et al.  Two growth factors and two hormones regulate initiation of DNA synthesis in cultured mouse cells through different pathways of events. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[47]  Gage Martin Rous Sarcoma Virus: a Function required for the Maintenance of the Transformed State , 1970, Nature.

[48]  C. Der,et al.  Transforming genes of human bladder and lung carcinoma cell lines are homologous to the ras genes of Harvey and Kirsten sarcoma viruses. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[49]  D. V. Von Hoff,et al.  Prospective clinical trial of a human tumor cloning system. , 1983, Cancer research.

[50]  M. Sporn,et al.  Transforming growth factor-β controls receptor levels for epidermal growth factor in NRK fibroblasts , 1984, Cell.

[51]  Cori Bargmann,et al.  Mechanism of activation of a human oncogene , 1982, Nature.

[52]  C. Petropoulos,et al.  Expression of a cellular oncogene during liver regeneration. , 1983, Science.

[53]  Robert A. Weinberg,et al.  Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes , 1983, Nature.

[54]  C. P. Leblond,et al.  Identification of Stem Cells in the Small Intestine of the Mouse , 1976 .

[55]  R. Lim,et al.  A rapid decrease in epidermal growth factor-binding capacity accompanies the terminal differentiation of mouse myoblasts in vitro , 1984, The Journal of cell biology.

[56]  T. Libermann,et al.  Expression of epidermal growth factor receptors in human brain tumors. , 1984, Cancer research.

[57]  R. Craig,et al.  Early decline in c-myb oncogene expression in the differentiation of human myeloblastic leukemia (ML-1) cells induced with 12-O-tetradecanoylphorbol-13-acetate. , 1984, Cancer research.

[58]  R. Hill,et al.  Biologic discussions augmenting radiation effects and model systems , 1975, The Laryngoscope.

[59]  C. Mummery,et al.  Loss of EGF binding and cation transport response during differentiation of mouse neuroblastoma cells , 1983, Journal of cellular biochemistry.

[60]  W. Mackillop,et al.  Measurement of self-renewal in culture of clonogenic cells from human ovarian carcinoma. , 1981, British Journal of Cancer.

[61]  H. Varmus,et al.  DNA related to the transforming gene(s) of avian sarcoma viruses is present in normal avian DNA , 1976, Nature.

[62]  Mcculloch Ea Abnormal myelopoietic clones in man. , 1979 .

[63]  C. Laboisse,et al.  Growth and differentiation of human gastrointestinal adenocarcinoma stem cells in soft agarose. , 1981, Cancer research.

[64]  Izaguirre Ca Colony formation by lymphoid cells , 1984 .

[65]  M. Sporn,et al.  Autocrine secretion and malignant transformation of cells. , 1980, The New England journal of medicine.

[66]  M. Minden,et al.  Self-renewal in culture of proliferative blast progenitor cells in acute myeloblastic leukemia. , 1979, Blood.

[67]  Paul Stroobant,et al.  Platelet-derived growth factor is structurally related to the putative transforming protein p28sis of simian sarcoma virus , 1983, Nature.

[68]  E. McCulloch,et al.  Mouse myeloma tumor stem cells: a primary cell culture assay. , 1971, Journal of the National Cancer Institute.

[69]  J. Meyer,et al.  Low incidence of estrogen receptor in breast carcinomas with rapid rates of cellular replication , 1977, Cancer.

[70]  D. Lowy,et al.  Tumorigenic transformation of mammalian cells induced by a normal human gene homologous to the oncogene of Harvey murine sarcoma virus , 1982, Nature.

[71]  E. Gelmann,et al.  Expression of cellular homologues of retroviral onc genes in human hematopoietic cells. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[72]  G. Guroff Growth and Maturation Factors , 1984 .

[73]  R. Weinberg,et al.  Isolation of a transforming sequence from a human bladder carcinoma cell line , 1982, Cell.

[74]  W. Lim,et al.  Comparison of two soft-agar methods for assaying chemosensitivity of human tumours in vitro: malignant melanomas. , 1981, British Journal of Cancer.

[75]  J. Till,et al.  A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. , 1961, Radiation research.

[76]  Y H Xu,et al.  Amplification and enhanced expression of the epidermal growth factor receptor gene in A431 human carcinoma cells. , 1984, Science.

[77]  Mackillop Wj,et al.  Cellular heterogeneity in human ovarian carcinoma studied by density gradient fractionation. , 1982 .

[78]  S. Salmon,et al.  Inhibition of human melanoma colony formation by retinoids. , 1979, Cancer research.

[79]  V. Courtenay,et al.  In vitro and in vivo radiosensitivity of human tumour cells obtained from a pancreatic carcinoma xenograft , 1976, Nature.

[80]  J. Trent,et al.  Direct cloning of human ovarian carcinoma cells in agar. , 1978, Cancer research.

[81]  S. Salmon Cloning of human tumor stem cells , 1980 .

[82]  A. Ciampi,et al.  A stem cell model of human tumor growth: implications for tumor cell clonogenic assays. , 1983, Journal of the National Cancer Institute.

[83]  I. Tannock,et al.  A critical appraisal of the "human tumor stem-cell assay". , 1983, The New England journal of medicine.

[84]  I. Verma,et al.  Differential expression of cellular oncogenes during pre- and postnatal development of the mouse , 1982, Nature.

[85]  R. Buick Cell heterogeneity in human ovarian carcinoma , 1984, Journal of cellular physiology. Supplement.

[86]  D. Alberts,et al.  Effect of 13‐cis‐retinoic acid and 4‐hydroxyphenyl‐all‐trans‐retinamide on human tumor colony formation in soft agar , 1983, International journal of cancer.

[87]  H. E. Gray,et al.  Cell-cycle control of c-myc but not c-ras expression is lost following chemical transformation , 1984, Cell.

[88]  G. Cooper,et al.  Transforming activity of human tumor DNAs. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[89]  A. Houweling,et al.  Partial transformation of primary rat cells by the leftmost 4.5% fragment of adenovirus 5 DNA. , 1980, Virology.

[90]  P. Vogt,et al.  Differences between the Ribonucleic Acids of Transforming and Nontransforming Avian Tumor Viruses* , 1970, Proceedings of the National Academy of Sciences.

[91]  M. Moore,et al.  Agar culture studies in 127 cases of untreated acute leukemia: the prognostic value of reclassification of leukemia according to in vitro growth characteristics. , 1974, Blood.

[92]  A. Hamburger,et al.  Primary bioassay of human tumor stem cells. , 1977, Science.

[93]  P. Rous Transmission of a malignant new growth by means of a cell-free filtrate. , 1973, Connecticut medicine.

[94]  A. Hamburger,et al.  Effect of epidermal growth factor on proliferation of human tumor cells in soft agar. , 1981, Journal of the National Cancer Institute.

[95]  E. McCulloch,et al.  Chemotherapy of mouse myeloma: quantitative cell cultures predictive of response in vivo. , 1973, Blood.

[96]  B. Lord,et al.  Growth Kinetics of Tumours , 1978, British Journal of Cancer.

[97]  B. Hoogstraten,et al.  Improved growth of in vitro colonies in human acute leukemia with the feeding culture method. , 1977, Cancer research.

[98]  J. Minna,et al.  Positive correlation between histological tumor involvement and generation of tumor cell colonies in agarose in specimens taken directly from patients with small-cell carcinoma of the lung. , 1980, Cancer research.

[99]  M. Minden,et al.  Proliferative state of blast cell progenitors in acute myeloblastic leukemia (AML) , 1978 .

[100]  D. Boettiger,et al.  Effect of src infection on long-term marrow cultures: Increased self-renewal of hemopoietic progenitor cells without leukemia , 1984, Cell.

[101]  R. Weinberg,et al.  Human EJ bladder carcinoma oncogene is homologue of Harvey sarcoma virus ras gene , 1982, Nature.

[102]  S. Salmon,et al.  Effect of host-cell interactions on clonogenic carcinoma cells in human malignant effusions. , 1980, British Journal of Cancer.

[103]  G. Carpenter,et al.  Antibodies to the epidermal growth factor receptor block the biological activities of sarcoma growth factor. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[104]  L. Lajtha,et al.  A comparison of cell replacement in bone marrow, testis and three regions of surface epithelium. , 1979, Biochimica et biophysica acta.

[105]  G. Spitzer,et al.  Colony formation in vitro by leukaemic cells in acute myelogenous leukaemia with phytohaemagglutinin as stimulating factor , 1976, Nature.

[106]  Hamburger Aw,et al.  Interaction between macrophages and human tumor clonogenic cells. , 1982 .

[107]  J. Trent,et al.  Direct cloning of human neuroblastoma cells in soft agar culture. , 1980, Cancer research.

[108]  Communication MODULATION OF CLONOGENIC HUMAN MELANOMA CELLS BY FOLLICLE-STIMULATING HORMONE , MELATONIN , 2007 .

[109]  J. Mendelsohn,et al.  Growth inhibition of human tumor cells in athymic mice by anti-epidermal growth factor receptor monoclonal antibodies. , 1984, Cancer research.

[110]  R. Weinberg,et al.  Cellular oncogenes and multistep carcinogenesis. , 1983, Science.

[111]  V. Courtenay,et al.  A colony-forming assay for human tumour xenografts using agar in diffusion chambers. , 1976, British Journal of Cancer.